Indianapolis, IN, United States of America

Scott Eugene Conner

This inventor holds 20 USPTO granted patents and 4 published patent applications and 6 EPO patents, primarily in Pharmaceutical Compounds. Top assignee: Eli Lilly and Company. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Eugene Conner. Retrieved from https://idiyas.com/inventor/scott-eugene-conner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 4)

% Patents Active = 25.0

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 63(Granted Patents)

Location History:

Elizabethtown, IN (US) (2006 - 2008)
Indianapolis, IN (US) (2008 - 2014)

Company Filing History:

20 out of 4,517

Eli Lilly and Company

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

cGAS Inhibitors

ATR Antagonists

Glucagon Receptor Antagonists

PPAR Modulators

Sulfonamide Derivatives

Fused Heterocyclic Derivatives

Pyrrole-2,5-Dione Derivatives

Oxazolyl-Aryloxyacetic Acid

GSK-3 Inhibitors

Therapeutic Uses

Substituted Thiophene

Preparation Methods

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723046 - cGAS inhibitors (2026-09-01),

2. 12122750 - ATR antagonists and uses thereof (2024-10-22),

3. 8691856 - Glucagon receptor antagonists, preparation and therapeutic uses (2014-04-08),

4. 8609892 - Glucagon receptor antagonists, preparation and therapeutic uses (2013-12-17),

5. 8084489 - Glucagon receptor antagonists, preparation and therapeutic uses (2011-12-27),

6. 8076374 - Glucagon receptor antagonists, preparation and therapeutic uses (2011-12-13),

7. 7989457 - Glucagon receptor antagonists, preparation and therapeutic uses (2011-08-02),

8. 7816557 - Glucagon receptor antagonists, preparation and therapeutic uses (2010-10-19),

9. 7807702 - Substituted thiophene carboxylic amide glucagon receptor antagonists, preparation and therapeutic uses (2010-10-05),

10. 7696248 - Glucagon receptor antagonists, preparation and therapeutic uses (2010-04-13),

11. 7655641 - Sulfonamide derivatives as PPAR modulators (2010-02-02),

12. 7598266 - Fused heterocyclic derivatives as PPAR modulators (2009-10-06),

13. 7528160 - Fused heterocyclic derivatives as PPAR modulators (2009-05-05),

14. 7405305 - Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors (2008-07-29),

15. 7396850 - Pyrazole derivative as PPAR modulator (2008-07-08),

As a website specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I would be delighted to provide you with an article about the renowned inventor Scott Eugene Conner and his impact on the world of innovation.

Title: Scott Eugene Conner: A Visionary Inventor Inspiring Future Generations

Introduction:

Scott Eugene Conner, a visionary inventor hailing from Indianapolis, IN (US), has left an indelible mark on the realm of innovation. With 18 patents to his name, his inventive spirit continues to ignite creativity and push boundaries in the world of invention.

Latest Patents:

Among his latest patents is the groundbreaking work on "Glucagon receptor antagonists, preparation and therapeutic uses." This invention unveils novel compounds with glucagon receptor antagonist or inverse agonist activity, offering promising approaches to treat diabetic and other glucagon-related metabolic disorders.

Career Highlights:

Scott Eugene Conner's career is interwoven with success at Eli Lilly and Company. His inventive prowess has thrived within this esteemed organization, leading to the development of cutting-edge solutions that address critical healthcare challenges.

Collaborations:

Throughout his journey, Scott has collaborated with exceptional professionals like Guoxin Zhu and Nathan Bryan Mantlo. Together, they have synergized their expertise to bring innovative ideas to fruition and advance the frontiers of science and technology.

Conclusion:

In conclusion, Scott Eugene Conner stands as a beacon of ingenuity and inspiration in the realm of innovation. His legacy as a visionary inventor resonates with aspiring inventors, encouraging them to think innovatively and pursue their inventive ideas with unwavering determination.

If you require additional information or have further inquiries about inventors, innovations, or patents, do not hesitate to reach out.

Profile summary based on public USPTO records.